Dexmedetomidine and Adenosine: Therapeutic Use for SVT

Completed · Not applicable

Conditions studied: Supraventricular Tachycardia

In brief

The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the acute termination of Supraventricular Tachycardia (SVT).

Key facts

Study ID

NCT01495481

Run by

University of Pittsburgh

People needed

22

Starts

2012-01-01

Expected to finish

2014-07-01

Last updated by the study team

2017-03-28

Who can join

Age: 5 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients between the age of 5 - 30 years old, who are scheduled for cardiac electrophysiology study for evaluation of reentrant SVT

You may not qualify if…

• Severe Heart Failure
• Presence of of any other antiarrhythmic medication within 24 hours of enrollment
• Third degree heart block
• Sick Sinus Syndrome

Where it is running

• Childrens Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.